Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Ancara Logistics Indonesia Tbk. (ALII) vs Tempo Scan Pacific Tbk. (TSPC)

Ancara Logistics Indonesia Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Ancara Logistics Indonesia Tbk. dan Tempo Scan Pacific Tbk.: Ancara Logistics Indonesia Tbk. diperdagangkan di Rp795 (kapitalisasi pasar 12,58 T, volume 24 jam 909,5 rb), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.770 (kapitalisasi pasar 12,58 T, volume 24 jam 227,8 rb). Perbedaan utamanya: Ancara Logistics Indonesia Tbk. dan Tempo Scan Pacific Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan Ancara Logistics Indonesia Tbk. lebih aktif diperdagangkan (909,5 rb vs 227,8 rb). Mana yang lebih baik tergantung tujuan investasimu.

ALIITSPC
Kapitalisasi Pasar
12,58 T12,58 T
Volume
909,5 rb227,8 rb
Lot
9,1 rb2,28 rb
Perputaran
740,25 jt629,37 jt
Harga Rata-rata
813,912.762,83
Nilai Transaksi
740,25 jt629,37 jt
Harga Ekuilibrium Indikatif
8202.780
Volume Ekuilibrium Indikatif
4669

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ALII
Lihat detail
TSPC
Lihat detail

Tentang Ancara Logistics Indonesia Tbk.

PT Ancara Logistics Indonesia Tbk (the Company) was established in the Republic of Indonesia on July 30, 2019 within the framework of the Foreign Direct Investment Law No. 25 Year 2007 based on Notarial Deed No. 437, of Netty Maria Machdar, SH., notary. The Company started its commercial operations in July 2020.

Selengkapnya di halaman ALII

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC